WC Pharmaceuticals

Warner Chilcott was a leading global specialty pharmaceutical company focused on the development, manufacture, and promotion of branded products in the women's healthcare, gastroenterology, dermatology, and urology segments. The company maintained a strong presence in the North American and Western European markets, driven by a portfolio of established brands such as Actonel, Asacol, and Lo Loestrin Fe. Warner Chilcott was known for its expertise in product life cycle management and its focused marketing approach targeting high-prescribing specialists. In 2013, the company was acquired by Actavis (now part of AbbVie) in an $8.5 billion transaction, significantly expanding Actavis's specialty brand portfolio.